Eradication of Helicobacter pylori reduces metachronous gastric cancer after endoscopic resection of early gastric cancer

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 776-780

  Seo, Ji Yeon ^a   Lee, Dong Ho ^b   Cho, Yuri ^a   Lee, Dong Hyeon ^a   Oh, Hong Sang ^a   Jo, Hyun Jin ^b   Shin, Cheol Min ^b   Lee, Sang Hyub ^b   Park, Young Soo ^b   Hwang, Jin Hyeok ^b   Kim, Jin Wook ^b   Jeong, Sook Hyang ^b   Kim, Nayoung ^b   Jung, Hyun Chae ^a   Song, In Sung ^b  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Atrophic gastritis; Endoscopic resection; Eradication; Helicobacter pylori; Intestinal metaplasia; Metachronous gastric cancer

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CELL INFILTRATION; EARLY CANCER; ENDOSCOPIC SURGERY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER;

BIOPSY; BREATH TESTS; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84879590506     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12929     Document Type: Article

References (21)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans 1994; 77:1017-1606.
2. Uemura N, Okamoto S, Yamamoto S, et al.: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
3. Correa P, Haenszel W, Cuello C, et al.: Model for gastric cancer epidemiology. Lancet 1975; 2:58-60.
4. Malfertheiner P, Megraud F, O'Morain C, et al.: Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 2007; 56:772-781. (Pubitemid 46854190)
5. Asaka M, Kato M, Takahashi S, et al.: Guidelines for the management of Helicobacter pylori infection in Japan: 2009 Revised Edition. Helicobacter 2010; 15:1-20.
6. Uemura N, Mukai T, Okamoto S, et al.: Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:639-642. (Pubitemid 27342688)
7. Onoda N, Katsuragi K, Sawada T, et al.: Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer. J Exp Clin Cancer Res 2005; 24:515-521. (Pubitemid 43139543)
8. Hamaguchi K, Ogawa K, Katsube T, et al.: Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbecks Arch Surg 2004; 389:83-91. (Pubitemid 38660676)
9. Matsukura N, Tajiri T, Kato S, et al.: Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric Cancer 2003; 6:100-107. (Pubitemid 36829964)
10. Salih BA, Abasiyanik MF, Saribasak H, et al.: A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. Digest Dis Sci 2005; 50:1517-1522. (Pubitemid 41039202)
11. Fukase K, Kato M, Kikuchi S, et al.: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372:392-397.
12. Wong BCY, Lam SK, Wong WM, et al.: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China - a randomized controlled trial. Jama-J Am Med Assoc 2004; 291:187-194. (Pubitemid 38082812)
13. Fuccio L, Laterza L, Zagari RM, et al.: Treatment of Helicobacter pylori infection. Brit Med J 2008; 337:a1454.
14. Shiotani A, Uedo N, Iishi H, et al.: Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008; 78:113-119.
15. Wong BC, Lam SK, Wong WM, et al.: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291:187-194. (Pubitemid 38082812)
16. Fuccio L, Zagari RM, Minardi ME, et al.: Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharm Therap 2007; 25:133-141. (Pubitemid 46046370)
17. Giuliani A, Galati G, Demoro M, et al.: Screening of Helicobacter pylori infection after gastrectomy for cancer or peptic ulcer results of a cohort study. Arch Surg-Chicago 2010; 145:962-967.
18. Correa P, Fontham ET, Bravo JC, et al.: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92:1881-1888. (Pubitemid 32036918)
19. Moertel CG: Multiple primary malignant neoplasms: historical perspectives. Cancer 1977; 40:1786-1792.
20. Nasu J, Doi T, Endo H, et al.: Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy 2005; 37:990-993. (Pubitemid 41489269)
21. Asaka M, Kato M, Graham DY: Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 2010; 49:633-636.